| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Upland | Consumer & Lifestyle Gaming | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $26.92M | Series A-3 | 10/21/2023 | $7M | $318.14M | $31.80 | Animoca Brands, C3 Management, EOS Network Ventures | ||||
 | Verge Genomics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $167.53M | Series C* | 9/8/2023 | $42M | $403.75M | $7.19 | Alexion, AstraZeneca, Alumni Ventures, Tenmile | ||||
 | Voyage Foods | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $97.73M | Series B | 12/5/2025 | $3.25M | $270.05M | $6.39 | 885 Capital, Cerity Partners Ventures | ||||
 | WideOrbit | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $33.19M | Series D | 10/6/2008 | $10.32M | $96.48M | $0.64 | Mayfield, Khosla Ventures, Greycroft Partners, Paul Bricault, SharesPost, Hearst Ventures | ||||
 | WorkBoard | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $157.48M | Series D-1 | 5/27/2025 | $9M | $101.9M | $0.33 | Undisclosed Investors | ||||
 | World View | Industrial Aerospace & Defense | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $222.01M | Series D-1 | 5/8/2025 | $21.7M | $207.66M | $0.05 | Undisclosed Investors | ||||
 | Yumi | Foodtech Food Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $115.16M | Series A-2 | 12/28/2023 | $19.08M | $43.24M | $0.26 | Undisclosed Investors | ||||
 | Zeitview | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $289.25M | Series E-3 | 1/27/2026 | $102.55M | $432.39M | $1.00 | Octant Ventures | ||||
 | Zoosk | Consumer & Lifestyle Social | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $62.45M | Series E | 1/27/2012 | $21.1M | $226.67M | $4.19 | Crosslink Capital, Crossroads Capital, ATA Ventures, Bessemer Venture Partners, Canaan Partners | ||||
 | 1Kosmos | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $62.03M | Series B-1 | 8/12/2025 | $27.72M | $274.03M | $10.45 | Forgepoint Capital, Oquirrh Ventures, Craig Abod, NextEra Energy, Gula Tech Adventures, Sprout & Oak | ||||
 | Accelus | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $6.08M | Series 2 | 5/29/2025 | $1.75M | $45.61M | $1.00 | Concord Health Partners | ||||
 | Act-On | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $38.38M | Series F | 3/18/2021 | $9.38M | $24.81M | $0.32 | U.S. Venture Partners, TCV, Norwest Venture Partners, Voyager Capital, Raghu Raghavan, Beedie Capital | ||||
 | AerNos | Industrial Industrial Equipment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $5.63M | Series A | 9/1/2017 | $5.63M | $36.64M | $0.66 | Undisclosed Investors | ||||
 | Airware (pre-spinoff) | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $101.13M | Series C1 | 5/26/2016 | $3M | $194.99M | -- | Danhua Capital and other undisclosed investors | ||||
 | Akhan Semiconductor | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $54.54M | Series A-1 | 1/24/2023 | $19.46M | $32.52M | $0.26 | Undisclosed Investors | ||||
 | Alloplex Biotherapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $20.67M | Series A | 1/27/2023 | $20.67M | $279.9M | $68.60 | Undisclosed Investors | ||||
 | Alt | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $212.89M | Series B | 11/11/2021 | $75.63M | $326.32M | $10.56 | Spearhead, Seven Seven Six, Vibe Capital, Breyer Capital, Shrug Capital, Apollo Projects, Hyperguap, A* | ||||
 | Alveus Therapeutics | Healthcare Other Healthcare | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $202.01M | Series A | 2/24/2026 | $197M | $290.11M | $20.00 | New Rhein Healthcare Investors, Andera Partners, Omega Funds, Sanofi Capital, Kurma Partners, Avego Management, Jeito Capital, Novo Holdings, Agent Capital, Seroba Lifesciences, Global BioAccess Fund | ||||
 | Amberdata | Fintech Blockchain | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $48.26M | Series B-1 | 5/4/2022 | $15.36M | $342.67M | $13.03 | Knollwood Investment Advisory Susquehanna International Group, Nasdaq Ventures, NAB Ventures, Chicago Trading Company, Nexo, Coinbase, Innovius, Citi, Franklin Templeton, Aspenwood Ventures, Rovida Kruptos Assets, Boldstart Ventures | ||||
 | Andium | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $49.36M | Series B-4 | 9/29/2025 | $4.12M | $168.89M | $11.21 | Undisclosed Investors | ||||
 | Ansun Biopharma | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $165.2M | Series B | 8/15/2018 | $100M | $466.82M | $1.49 | Lilly Asia Ventures, Matrix Partners China, Yuanming Capital, Lyfe Capital, 3E Bioventures | ||||
 | Anyvoice | Consumer & Lifestyle Other Consumer & Lifestyle | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.23M | Series A | 10/20/2025 | $41.54M | $294.73M | $1.50 | Undisclosed Investors | ||||
 | Apexigen | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $165.38M | Series C | 3/24/2020 | $127.86M | $343.82M | $1.55 | Decheng Capital, Oceanpine Capital, 3E Bioventures Capital, VI Ventures, SV Tech Ventures, H&Q Asia Pacific, LDV Ventures, ShangBay Capital, Delian Capital, Hua Nan Venture Capital, Efung Capital | ||||
 | Arthrosi Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $294.54M | Series E | 10/8/2025 | $148.1M | $385.03M | $6.54 | Prime Eight Capital, CR Biotech, HighLight Capital, HM Venture Partners, ReliantTech | ||||